申请人:Gambacorti Passerini Carlo
公开号:US20110112110A1
公开(公告)日:2011-05-12
Inhibitors of the oncogenic tyrosine kinase ALK and of the Bcr-Abl mutant T315I Bcr-Abl, pharmaceutical compositions containing the same and their use for the treatment of hyper-proliferative diseases.
抑制癌基因酪氨酸激酶ALK和Bcr-Abl突变体T315I Bcr-Abl的抑制剂,包含它们的制药组合物以及它们用于治疗高增殖性疾病的用途。